Status of progress of bulk drug parks in Gujarat

• Bulk Drug Parks are dedicated industrial clusters offering Common Infrastructure Facilities (CIF) to Active Pharmaceutical Ingredient (API) / Key Starting Material (KSM) manufacturers at subsidised rates.
• Aim: cut import dependence on China for bulk drugs, achieve economies of scale, and lower domestic API manufacturing cost.
• Gujarat hosts one of the three approved parks (with Andhra Pradesh and Himachal Pradesh); examinable as part of GS-III (Indian economy / pharma sector / Atmanirbhar Bharat).